Skip to content

Virtual Ileostomy Versus Conventional Loop Ileostomy

Virtual Ileostomy Versus Conventional Loop Ileostomy in Patients Undergoing Low Anterior Resection for Rectal Cancer: A Randomized Controlled Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05985252
Enrollment
500
Registered
2023-08-14
Start date
2023-10-01
Completion date
2025-12-31
Last updated
2023-08-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Neoplasms

Keywords

Virtual ileostomy, Diverting ileostomy, Rectal Neoplasms, Rectosigmoid junction

Brief summary

This study aimed at comparing the Comprehensive Complication Index (CCI), readmission rates, postoperative hospitalization days, duration of bearing the stoma (months), hospitalization costs, the number of hospitalizations with ghost ileostomy versus conventional loop ileostomy after low anterior resection for rectal cancer.

Detailed description

Diverting ileostomy (DI) is a common procedure performed in patients undergoing low anterior resection for rectal cancer to protect the anastomosis and reduce the risk of complications. Although DI remains one of the most common methods used in clinical practice to prevent anastomotic leakage, there is still considerable debate in clinical practice about whether to perform a routine ileostomy. Despite temporary ileostomy fecal diversion can reduce the development of abdominal abscesses, wound inflammation, peritonitis, and sepsis after the occurrence of AL, however, it not only failed to reduce the incidence of AL but significantly increased the risk of non-elective readmissions and reinterventions as well as higher total costs. Meanwhile, stoma significantly increase the risk of stoma-related complication such as small bowel obstruction, postoperative ileus, dehydration from high-output stoma culminating in acute kidney injury, electrolyte imbalance, stoma stenosis/ necrosis, parastomal hernia, peristomal abscess, and fistula, etc.

Interventions

Laparoscopic or robotic surgery with virtual ileostomy

Laparoscopic or robotic surgery with diverting ileostomy

Sponsors

Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Pathologically confirmed low to intermediate level rectal cancer, with the lower margin of anastomosis \<10cm from the anus. * age ≥18 years and ≤80 years. * the surgical procedure is anterior rectal resection (LAR). * intraoperative virtual or conventional ileostomy was performed.

Exclusion criteria

* BMI \>30 kg/m². * ASA score \>3. * Patients with coexisting complete intestinal obstruction. * History of long-term use of immunosuppressive drugs or glucocorticoids. * Combined severe cardiac disease: with congestive heart failure or NYHA cardiac function ≥ grade 2. Patients with a history of myocardial infarction or coronary artery surgery within 6 months prior to the procedure. * chronic renal failure (requiring dialysis or glomerular filtration rate \<30 mL/min). Intraoperative combined multi-organ resection. * Combined cirrhosis of the liver. * Intraoperative findings of incomplete anastomosis and positive insufflation test.

Design outcomes

Primary

MeasureTime frameDescription
Calculation postoperative of the Comprehensive Complication Index (CCI) for each patientAn average of 1 year from the date of low anterior resection for rectal cancer until the date of when the patient's condition is stabilized without complicationsThe Comprehensive Complication Index (CCI)summarises all postoperative complications based on the established Clavien-Dindo classification (ranging from mild complications not leading to a deviation from the normal clinical course (grade I) up to postoperative death (grade V)) at an individual patient level according to their grade of severity.

Secondary

MeasureTime frameDescription
Postoperative hospitalization daysThrough study completion, an average of 1 yearPatients in the virtual stoma group who did not have a second surgery due to complications recorded days of postoperative hospitalization after low anterior resection for rectal cancer, if the virtual stoma group required bedside or secondary surgery for diverting ileostomy due to complications and all patients in the diverting ileostomy group required reoperation for stoma reversal, record days of postoperative hospitalization due to complications and/or reoperation since the data of low anterior resection for rectal cancer.
Readmission ratesThrough study completion, an average of 1 yearPatients in the virtual stoma group who did not have a second surgery due to complications recorded the number of hospitalization after low anterior resection for rectal cancer. If the virtual stoma group required bedside or secondary surgery for diverting ileostomy due to complications and all patients in the diverting ileostomy group required reoperation for stoma reversal, record the number of hospitalization due to complications and/or reoperation since the data of low anterior resection for rectal cancer.
The number of hospitalizationsThrough study completion, an average of 1 yearPatients in the virtual stoma group who did not have a second surgery due to complications recorded the number of hospitalization after low anterior resection for rectal cancer. If the virtual stoma group required bedside or secondary surgery for diverting ileostomy due to complications and all patients in the diverting ileostomy group required reoperation for stoma reversal, record the number of hospitalization due to complications and/or reoperation since the data of low anterior resection for rectal cancer.
Duration of bearing the stoma (months)Through study completion, an average of 1 yearIf the virtual stoma group required bedside or secondary surgery for diverting ileostomy due to complications and all patients in the diverting ileostomy group required reoperation for stoma reversal, record the duration of bearing the stoma since the data of surgery of diverting ileostomy.
First hospitalization costsDuring hospitalization,approximately 7 daysPatient hospitalization costs for radical resection of rectal cancer.
Total hospitalization costsThrough study completion, an average of 1 yearPatients in the virtual stoma group who did not have a second surgery due to complications recorded the costs after low anterior resection for rectal cancer, if the virtual stoma group required bedside or secondary surgery for diverting ileostomy due to complications and all patients in the diverting ileostomy group required reoperation for stoma reversal, record the costs due to complications and reoperation since the data of low anterior resection for rectal cancer.

Other

MeasureTime frameDescription
Whether patients undergo terminal ostomy after low anterior resection for rectal cancer.Through study completion, an average of 1 yearHartmann's procedure or for example, abdominoperineal extirpation
Patients with stoma (terminal/loop) at 6 months after initial surgery6 months from the date of low anterior resection for rectal cancerPatients carrying stoma 6 months after low anterior resection for rectal cancer.
The number of participants with virtual ileostomy converted to diverting ileostomyThrough study completion, an average of 1 yearThe virtual stoma required bedside or secondary surgery for diverting ileostomy due to complications.
The number of patients who required secondary abdominal surgery under general anesthesia due to complicationsThrough study completion, an average of 1 yearPatient undergoes second abdominal surgery for complications after first surgery
Ghost ileostomy remove timeDuring hospitalization,approximately 7 daysDuration of days from the date of radical resection of rectal cancer to virtual stoma removed.
The number of patients with complications after low anterior resection for rectal cancerThrough study completion, an average of 1 yearAbdominal abscess,Anastomotic bleeding,Pelvic infection,Surgical incision infection, Peritonitis,Interventional drainage ,ileostomy wounds/abscesses/edema/dermatitis/ ulcers,Parastomal hernia ,Stoma prolapse,Anastomotic separation/poor healing, Anastomotic stenosis,Anastomotic leakage,Bowel obstruction,Anastomotic bowel necrosis ,Wound dehiscence / bleeding / sinus tract / abscess/fat liquefaction,Acute kidney injury ,Dehydration/output \>1500 mL/day,Converted to permanent ileostomy,Intestinal fistula,Incisional hernia ,fecal incontinence.
Adjuvant chemotherapy in patients after low anterior resection for rectal cancer.6 months from the date of low anterior resection for rectal cancerWhether the patient has completed chemotherapy.

Countries

China

Contacts

Primary Contactfan li
levinecq@163.com+86 023 68757958

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026